Novartis has increased its annual dividend by 7% and continued to take steps to improve productivity as group net sales rose by 2% to $57.9 billion in 2013 but operating income declined by 3% to $10.9 billion. Sales of pharmaceuticals were flat. ---Subscribe to MedNous to access this article--- Company News
